Karen H. Costenbader

Autoantibody Clusters and SIGLEC1 are Predictive of Systemic Lupus Erythematosus Development

Objectives Up to one-third of patients with suspected SLE progress to definite disease, but reliable predictive markers are lacking. Previously, we developed a Lupus Lymphocyte Activation Score (LLAS) based on key cell subsets (transitional B cells, age-associated B cells, plasma...